The constant back pain caused by a painfully left Ash Basu left aroused curiosity when she thought she saw a hemp specialist.
At the age of 64, he had not experienced marijuana, fun, or any other experience, but had heard reports of the plant's pain-relieving potential and was eager to avoid opioids.
He was referred to a cannabis clinic and asked the doctor questions. She wasn't satisfied with what she heard.
In a new information session on medical marijuana in Toronto, Basu, among several dozen elderly, said, "He didn't know much."
Dair The problem I have is that there is no data about the interactions between all the drugs I take. I'm diabetes, I have high blood pressure, I'm in three different allergy medications. He takes a lot of medicine. "
Basu left the clinic with the authority to buy medicinal cannabis oil, but did not buy it two months later. He doesn't think he's coming soon.
Orum Really, I'm really afraid to try because I don't want any reaction and I don't want to fall. This is my biggest concern, ”says Mississauga, Ont.
There are a lot of questions of interest to marijuana among older people, says the CEO of the Longtime Care Association of Ontario's Candace Chartier.
The group has a great reason for a six-month pilot program. To monitor and monitor the effects of medical cannabis use among 500 elderly people at several Ontario long-term care facilities.
Medical marijuana benefits from a range of discomfort for many patients. Chartier says employees and family members are already reporting positive results as anecdotal.
Or It becomes effective, less time is needed to look at the inhabitants bak The carers at the level of pain see a difference, “he says.
”We know it works on a small scale, so we're excited to do it on a larger scale.“
Chartier said the OLTCA would coordinate the program and develop screening tools with cannabis company Canopy Growth, which provides cannabis to nurses, pharmacists, doctors and caregivers.
The results will inform the guidelines that can shape care at facilities across the country: "It will be a clinical support tool for every home in the province to benefit from it," he says.
In the meantime, a similar six-month study was conducted to examine the effect of medical cannabis on sleep, perception of pain, and quality of life in patients over 50 years of age. The cannabis company launched a six-month study, including Tilray.
Philippe Lucas, Tilray's vice president of global patient research and access, says the study will begin in Sarnia, Ont, and will eventually open to more clinics in British Columbia and New Brunswick in 2019.
He expects the patient to be enrolled from 600 to 1000 and is afraid of detailed data on how older people use cannabis and the consequences.
Uzun Any longitudinal monitoring of the effect of medical cannabis over time has not been a prospective study, Lucas says Lucas.
Dr. Tilray's Ontario study, including those living in long-term care facilities for seniors specializing in cannabinoid therapy Sarnia-based cannabis specialist Dr. It's led by Blake Pearson.
Pearson estimates that cannabis is not for everyone, but between 60 and 70 percent of patients receiving medical marijuana treatment have seen some sort of improvement.
"Most of the time, I can treat a geriatric patient with cannabis oil, and as a result I can potentially reduce two to three of their other drugs, because it's multimodal," says Pearson.
"So we can sleep with pain, anxiety, or something against three or four different drugs."
Chartier says that reducing drugs can not only improve the quality of life for the patient, but also, quality of workplace for staff, in long-term care facilities.
Or This can shorten the time of drug administration and almost halve, “he says.
Dr. Canopy's chief health officer. Mark Ware noted that medical cannabis research tends to focus on childhood epilepsy and middle-aged people with chronic pain and spasticity.
Rar The elderly haven't received much attention, and there's a good reason to think they can handle cannabinoids in a different way than a younger person, abil says the Montreal-based pain specialist, former mayor of a federal task force in Canada.
Ed They may require smaller doses, they can metabolize drugs more slowly. “
He took a big advantage in researching long-term care facilities.
Için There are very strong monitoring systems for drug use for neurocognitive symptoms for sleep and pain scores. So they are actually getting used to following the health of their residents. "
Basu said he is looking for arm-length research to objectively assess the use of medicinal cannabis for high-level use, and that he is skeptical of work related to the private sector. However, it attaches more importance to the concerns of the elderly.
Or Everything is about training, “he says. ”I think the industry needs to do more.“